BioSpace News Archive

Study: Biosimilars ‘Fulfilling Their Promise’ of Lowering Biologic Prices

Biosimilars effectively lowered cancer therapy Herceptin prices and made trastuzumab more accessible to patients, finds a new study from the USC Schaeffer Center.

June 7, 2023
·
2 min read
·
Tristan Manalac
Policy

FTC’s Challenge to Amgen-Horizon Merger Sparks Industry Attention

The Federal Trade Commission’s lawsuit takes an unusual strategy, according to legal experts, raising concerns and uncertainties in the biopharma industry.

June 7, 2023
·
4 min read
·
Lisa Munger
Polaris Group’s Strategic Partner Nanotein Technologies Launches GROW-NK, a Revolutionary NK Cell Activation and Expansion Reagent, Propelling the Field of NK Cell Therapy

Polaris Group (TWSE: 6550), a multinational biopharmaceutical company focused on research and development of novel biological drugs for cancer and other metabolic diseases, today announced...

June 7, 2023
·
2 min read
Policy

Moderna, Pfizer Hit with New COVID Vaccine Patent Lawsuits

Promosome filed lawsuits Tuesday against Moderna and Pfizer/BioNTech, alleging that the vaccine developers used patent-protected mRNA technology without a license.

June 7, 2023
·
2 min read
·
Tristan Manalac
Drug Development

FDA Adcomm Unanimously Backs Full Approval of Eisai, Biogen’s Leqembi

In a 6-0 vote, the FDA’s advisory committee Friday affirmed that trial data confirmed the clinical benefit of Eisai and Biogen’s Leqembi (lecanemab) for the treatment of Alzheimer’s disease.

June 7, 2023
·
3 min read
·
Rosemary Scott
Drug Development

FibroGen’s Duchenne Muscular Dystrophy Drug Fails Phase III Trial

In a late-stage study of non-ambulatory patients with DMD on background corticosteroids, pamrevlumab failed to meet the primary endpoint for upper limb performance.

June 7, 2023
·
2 min read
·
Kate Goodwin
Biotech Bay

Atara Biotherapeutics to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference

Atara Biotherapeutics, Inc. (Nasdaq: ATRA) today announced that Pascal Touchon, President and Chief Executive Officer, will participate in a fireside chat at the Goldman Sachs 44th Annual Global Healthcare Conference on Wednesday, June 14, 2023 at 4:00 p.m. PDT / 7:00 p.m. EDT.

June 7, 2023
·
1 min read
Genetown

Quanterix to Participate in Fireside Chat at Goldman Sachs Annual Global Healthcare Conference

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will speak at the Goldman Sachs Annual Global Healthcare Conference on June 14, 2023 at 10:40 a.m., PT.

June 7, 2023
·
1 min read
Genetown

Akoya Biosciences Announces Public Offering of Common Stock - June 07, 2023

Akoya Biosciences, Inc., The Spatial Biology Company®, announced it has launched an underwritten public offering of shares of its common stock.

June 7, 2023
·
3 min read
BioMidwest

Merit Medical Announces New Five-Year Senior Secured Credit Agreement

Merit Medical Systems, Inc., a leading global manufacturer and marketer of healthcare technology, announced that it has entered into a new, five-year senior secured credit agreement.

June 7, 2023
·
2 min read